THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS

The purpose of work – improving the efficiency of treating endometriosis by clarifying some aspects of the pathogenesis of endometriosis.

of the study – determining the expression of aromatase in atopicescom and ectopic endometrium, to identify the relationship of polymorphisms in the aromatase gene and gems of detoksikatsii to optimize the ingenious treatment of patients with endometriosis.

and methods. Definition of polymorphic gene variants of CYP19 was assessed by PCR with specific oligoprimers with subsequent restriction analysis.

the Expression of aromatase in the studied forms of endometriosis is positively correlated with the stage of disease. The "zero" variant of the gene GSTМ associated with pelvic pain of varying intensity, as well as recurrent forms of the disease (χ2 =of 8.78; p<0.05), which is important in the prediction of the clinical course of the disease. By gene GSTT1 any difference in the groups, as well as links with clinical manifestations of endometriosis was obtained. Conclusion. Detection of positive expression of aromatase in the ectopic foci, and also in the endometrium atopicescom when adenomiose (58%) and external endometriosis (80%), its relationship with stage distribution of the disease and the severity of pain allows us to consider this enzyme as a promising for the diagnosis and development of new approaches to the treatment of endometriosis with aromatase inhibitors. The study of associated gene polymorphisms of the aromatase CYP19 and detoxification GSTM can be recommended as a prognostic test for assessing the risk of development and prognosis the clinical course of endometriosis. About the Authors L. V. AdamyanRussian Federation Academician of RAS, MD, PhD, professor, Chief of the Department of reproductive medicine and surgery, Faculty of postgraduate professional education, ul. Delegatskaya, 20-1, Moscow, 127473 M. M. Sonova Russian Federation MD, PhD, professor of the Department of reproductive medicine and surgery, Faculty of postgraduate professional education, ul. Delegatskaya, 20-1, Moscow, 127473 O. N. Loginova Russian Federation MD, PhD, assistant of the Department of reproductive medicine and surgery, Faculty of postgraduate professional education, ul. Delegatskaya, 20-1, Moscow, 127473 K. N. Arslanyan Russian Federation MD, PhD, associate professor of the Department of reproductive medicine and surgery, Faculty of postgraduate professional education, ul. Delegatskaya, 20-1, Moscow, 127473

1. Adamyan L.V., Andreeva E.N. Genital endometriosis: etiopathogenesis, clinical picture, diagnosis, treatment. Methodological manual for doctors [Genital'nyi endometrioz: etiopatogenez, klinika, diagnostika, lechenie. Metodicheskoe posobie dlya vrachei (in Russian)]. Moscow. 2001. 2. Adamyan L.V., Kulakov V.I., Andreeva E.N. Endometriosis. Edition 2-e [Endometriozy. Izdanie 2-e (in Russian)]. Moscow. 2006; 416 s. 3. Baskakov V.P., Tsvelev Yu.V., Kira E.F. Endometriod disease [Endometrioidnaya bolezn' (in Russian)]. SPb. 2002; 452 s. 4. Krasnopol'skaya K.V, Kalugina. A.S. Problemy reproduktsii. 2001; 6: 24-28. 5. Savitskii G.A., Gorbushin S.M. Peritoneal endometriosis and infertility (clinicomorphological research) [Peritoneal'nyi endometrioz i besplodie (klinikomorfologicheskoe issledovanie) (in Russian)]. SPb. 2002; 170 s. 6. Sidorova I.S., Kogan E.A., Zairatyants O.V. et al. Akusherstvo i ginekologiya. 2002; 3: 32-38. 7. Strizhakov A.N., Davydov A.I. Endometriosis. Clinical and theoretical aspects [Endometrioz. Klinicheskie i teoreticheskie aspekty (in Russian)]. Moscow. 1995. 8. Unanyan A.L., Sidorova I.S., Levakov S.A., Guriev T.D., Ignat'eva N.N. New aspects of the pathogenesis of adenomyosis treatment in combination with uterine myoma. XIV Russian National Congress "Man and medicine". Collection of congress materials [Novye aspekty patogeneticheskoi terapii adenomioza v sochetanii s miomoi matki. XIV Rossiiskii natsional'nyi kongress «Chelovek i lekarstvo». Sbornik materialov kongressa (in Russian)]. Moscow. 2007; 230-231. 9. Abushahin F., Goldman K.N., Barbieri E., Milad M., Rademaker A., Bulun S.E. Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertility and Sterility. 2011; 96 (4): 939-942. DOI: https://doi.org/10.1016/j.fertnstert.2011.07.1136. 10. Ailwadi R.K., Jobanputra S., Kataria M. et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertility and Sterility. 2003; 81: 290-6. DOI: https://doi.org/10.1016/j.fertnstert.2003.09.029. 11. Bulun S.E., Zeitoun K., Takayama K., Noble L., Michael D., Simpson E., Johns A., Putman M., Sasano H. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer. 1999; 6 (2): 293-301. DOI: https://doi.org/10.1677/erc.0.0060293. 12. Bulun S.E., Zeitoun K.M., Kilic G. Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. Am J Obstet Gynecol. 2000; 182 (4): 767-75. DOI: https://doi.org/10.1016/s0002-9378(00)70325-5. 13. Bulun S.E., Yang S., Fang Z., Gurates B., Tamura M., Sebastian S. Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci. 2002; 955: 75-88. DOI: https://doi.org/10.1111/j.1749-6632.2002.tb02767.x. 14. Bulun Serdar E., Gonca Imir, Hiroki Utsunomiya, Thung Steven Bilgin Gurates, Mitsutoshi Tamura, Zhihong Lin. Aromatase in endometriosis and uterine leiomyomata. The Journal of Steroid Biochemistry and Molecular Biology. 2005; 95 (1-5): 57-62. DOI: http://dx.doi.org/10.1016/j.jsbmb.2005.04.012. 15. Bulun S.E, Lin Z., Zhao H., Lu M., Amin S., Reierstad S., Chen D.Ann. Regulation of aromatase expression in breast cancer tissue. N. Y. Acad Sci. 2009; 1155: 121-31. DOI: https://doi.org/10.1016/j.canlet.2008.05.038. 16. Bulun S.E. Endometriosis. N. Engl. J. Med. 2009; 360 (3): 268-79. DOI: https://doi.org/10.1056/nejmra0804690 . 17. Cobellis L., Razzi S., Fava A., Severi F.M., Igarashi M., Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertility and Sterility. 2004; 82 (1): 239-240. DOI: http://dx.doi.org/10.1016/j.fertnstert.2003.11.058 . 18. Dodson Michael M., Simpson Evan R. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of thehuman aromatase P450 (CYP19) gene. Molecular and Cellular Endocrinology.1997; 134 (2): 147 to 156. DOI: http://dx.doi.org/10.1016/s0303-7207(97)00178-0. 19. Halme J., Hammond M.D., Hulka J.F. et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. and Gynec. 1984; 64: 151-154. DOI: https://doi.org/10.1093/humupd/8.1.84. 20. Halme J., Becker S., Haskill S. Altered maturation and function reritoneal macrophages: possible role in pathogenesis of endometriosis. Amer. J. Obstet. Gynec. 1987; 156: 783-789. DOI: https://doi.org/10.1016/0002-9378(87)90333-4. 21. Halme J., Hammond M.D., Hulka J.F. et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. and Gynec. 1984; 64: 151-154. DOI: https://doi.org/10.1093/humupd/8.1.84 22. Hatem A.H. Potential role of aromatase inhibitors in the treatment of endometriosis. Int J Womens Health. 2014; 6: 671-680. DOI: 10.2147/IJWH.S34684. 23. Henzl M.R., Corson S.L., Moghissi K. et al. Administation of nasal nafarelin as compared with oral danasol for endometriosis. N. Engl. J. Med. 1988; 318: 485-9. DOI: https://doi.org/10.1056/nejm198802253180805. 24. Hill J.A. Immunology and endometriosis. Fertility and Sterility. 1992; 58: 262-4. DOI: https://doi.org/10.1016/s0015-0282(16)55213-3. 25. Huang J.C., Dawood M.Y., Wu K.K. Regulation of cyclooxygenase-2-gene in cultured endometrial stromal cells by sex steroids. Am. Soc. Reprod. Med. Meeting. 1996; 5. DOI: https://doi.org/10.1016/s0015-0282(98)00260-x. 26. Langoi D., Pavone M.E., Gurates B. , Chai D., Azleabas A.F., Bulun S.E. Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons. Fertility and Sterility. 2012; 99 (3): 656-662.e3. DOI: http://dx.doi.org/10.1016/j.fertnstert.2012.11.021. 27. Madny E. Efficacy of letrozole in treatment of endometriosis-related pain. Science direct. DOI: http://dx.doi.org/10.1016/j.mefs.2013.04.007. 28. Noble L.S, Simpson E.R., Johns A. et al. Aromatasae expression in endometriosis. J. Clinic Endocrinol. Metab. 1996; 81: 174-9. 29. Pavone M.E., Bulun S.E. Aromatase inhibitors for the treatment of endometriosis. Fertility and Sterility. 2012; 98 (6): 1370-1379. DOI: http://dx.doi.org/10.1016/j.fertnstert.2012.08.053. 30. Sambrook Joseph, Russell David W. Molecular Cloning: A Laboratory Manual. The Quarterly Review of Biology. 2001; 76 (3): 348-349. DOI: https://doi.org/10.1086/394015. 31. Taylor N.R., Hummelshoj L., Stratton P., Vercellini P. Pain and endometriosis: Etiology, impact, and therapeutics. Middle East Fertility Society Journal. 2012; 17 (4): 221-225. DOI: http://dx.doi.org/10.1016/j.mefs.2012.09.002 Review For citations: Adamyan L.V., Sonova M.M., Loginova O.N., Arslanyan K.N. THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS. Obstetrics, Gynecology and Reproduction. 2016;10(4):39-48. (In Russ.) https://doi.org/10.17749/2313-7347.2016.10.4.039-048 JATS XML This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.